정형외과용 임플란트 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Orthopedic Implants Market Growth & Trends:

The global orthopedic implants market size is estimated to reach USD 32.47 billion by 2030, expanding at a CAGR of 3.78% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in the frequency of musculoskeletal problems, the rising geriatric population, and high demand for joint replacement are all factors driving the growth. The increase in the use of orthopedic devices, issues with low bone density, the introduction of biodegradable implants & internal fixation devices, and a rise in the number of patients in their middle age choosing orthopedic implantable devices are other factors driving market growth.

The market is driven by the rising emergence of musculoskeletal disorders, the growing advent of biodegradable implants and internal fixation devices, and the growing elderly population. For instance, the aging population is propelling the demand for orthopedic solutions globally, and according to WHO's October 2022 estimates, by 2030, one in six people worldwide will be aged 60 years or older. In 2022, the population of people aged 60 years and above will rise to 1.4 billion from 1 billion in 2020. In addition, the upsurge in orthopedic device usage and the increasing number of middle-aged patients opting for orthopedic implants are further propelling market growth.

The demand for joint replacement and other related medical devices is expected to grow as prevalent chronic joint disorders such as osteoarthritis (OA) are witnessing an increasing number of patients, requiring the development and usage of advanced orthopedic implantable devices. Osteoarthritis (OA) is a common condition that affects many people, and it is projected to impact almost a billion people by 2050. Furthermore, in September 2023, according to a study titled "Global, regional, and national burden of OA, 1990-2020 and projections to 2050" highlighted that by 2050, cases of OA for the knee, hand, hip, and other types of OA will increase by significant percentages of 74.9%, 48.6%, 78.6%, and 95.1%, respectively.

The improvement in the regulatory landscape, along with ongoing efforts by industry players to innovate products that offer better bioactivity, biocompatibility, and suitable mechanical properties, is further driving market growth. Recently, in March 2022, Molecular Matrix, Inc. unveiled the commercial launch of its Synthetic Bone Graft, branded as Osteo-P. Primarily employed as a substitute in the musculoskeletal system, this product is developed using HCCP technology, which significantly benefits bone regeneration and repair processes.

Smart sensor-enabled technologies have revolutionized the field of orthopedic implants, offering advancements in monitoring, feedback, and customization. These technologies utilize sensors to gather real-time data on implant performance, patient movement, and physiological parameters, allowing personalized treatment & improved outcomes. For enhanced patient care throughout the treatment, smart implants feature inbuilt sensors that give surgeons real-time information for positioning and postoperative evaluation. These implants may reduce periprosthetic infection, which is becoming more common in orthopedic surgery. Healthcare professionals currently have a variety of distinctive, economical goods to choose from due to sensor-enabled technologies. In January 2021, Stryker Corporation announced the acquisition of OrthoSensor and its knee surgery sensor technology.

Several key players are acquiring other small-scale manufacturers to expand their product lines and strengthen their market positions. In a recent instance, in January 2023, Companion Spine announced the acquisition of Backbone SAS. Incorporating the primary medical device from the Backbone, the LISA implant, this acquisition broadened Companion Spine's array of medical implant solutions. Consequently, Companion Spine can now offer a comprehensive range of treatment options for spine ailments, such as lumbar stenosis and degenerative disc disease, by tailoring implants to the severity of the condition.

Orthopedic Implants Market Report Highlights:

• The lower extremity implants product segment held the largest revenue share in the market in 2024. This is due to the increasing prevalence of orthopedic conditions, advancements in implant materials and designs, and the growing demand for improved quality of life through surgical interventions.
• The hospitals end use segment held the largest revenue share. This can be attributed to significant infrastructure and a growing patient population.
• North America dominated the market due to the presence of a large number of major market players and the high adoption of advanced technologies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Material outlook
  • 2.2.3. Distribution Channel outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Orthopedic Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for smart orthopedic implants
    • 3.2.1.2. Growing population aged 25 to 65 years and increasing burden of global geriatric population
    • 3.2.1.3. Increasing adoption of minimally invasive treatments
    • 3.2.1.4. Increasing number of sports injuries and road traffic accidents
    • 3.2.1.5. Increasing reimbursement coverage
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulatory framework
    • 3.2.2.2. Increasing number of product recalls
    • 3.2.2.3. Availability of alternative treatments
• 3.3. Orthopedic digit implants: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Orthopedic Implants Market: Product Pipeline Analysis
• 3.5. Orthopedic Disease Prevalence
• 3.6. Go-to-Market Strategy Analysis
• 3.7. Initiatives by key stakeholders in the Orthopedic Industry
• 3.8. Emergence of Smart Implants and Applications and Software In The Orthopedic Industry
• 3.9. Orthopedic Technology Trends for 2024
• 3.10. Regulatory Landscape and Compliance
• 3.11. Total Joint Replacement/ Orthopedic Implants Segment Sales Performance
• 3.12. Impact of COVID-19 Pandemic on Orthopedic Devices Market
• 3.13. Supply Chain Management in the Orthopedic Implants Market

Chapter 4. Orthopedic Implants Market Segment Analysis, By Product, 2018-2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Segment Dashboard
• 4.3. Global orthopedic implants market, by Product, 2018 to 2030
• 4.4. Lower Extremity Implants
  • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Knee Implants
    • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Hip Implants
    • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Foot & Ankle Implants
    • 4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Spinal Implants
  • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Upper Extremity Implants
  • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.2. Elbow Implants
    • 4.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.3. Hand & Wrist Implants
    • 4.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.4. Shoulder Implants
    • 4.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Dental
  • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7.2. Dental Implants
    • 4.7.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7.3. Craniomaxillofacial Implants
    • 4.7.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Orthopedic Implants Market Segment Analysis, By End Use, 2018-2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Segment Dashboard
• 5.3. Global orthopedic implants market, by End Use, 2018 to 2030
• 5.4. Hospitals
  • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Outpatient Facilities
  • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Orthopedic Implants Market Segment Analysis, By Distribution Channel, 2018-2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Segment Dashboard
• 6.3. Global orthopedic implants market, by Distribution Channel, 2018 to 2030
• 6.4. Offline
  • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Online
  • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Orthopedic Implants Market Segment Analysis, By Region, 2018- 2030 (USD Million)

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Orthopedic Implants Market Share by Region, 2023 & 2030:
• 7.5. North America
  • 7.5.1. North America orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico orthopedic implants market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Framework
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Framework
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark orthopedic implants market, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Framework
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Framework
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Framework
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Framework
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand orthopedic implants market, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Framework
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina orthopedic implants market, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Framework
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Framework
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Framework
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE orthopedic implants market, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Framework
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait orthopedic implants market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis
• 8.4. List of OEM in the Market
• 8.5. List of private players
• 8.6. List of top 10 key players in the market
• 8.7. Company Profiles
  • 8.7.1. Medtronic
    • 8.7.1.1. Company overview
    • 8.7.1.2. Financial performance
    • 8.7.1.3. Product benchmarking
    • 8.7.1.4. Strategic initiatives
  • 8.7.2. DePuy Synthes (Johnson & Johnson)
    • 8.7.2.1. Company overview
    • 8.7.2.2. Financial performance
    • 8.7.2.3. Product benchmarking
    • 8.7.2.4. Strategic initiatives
  • 8.7.3. Stryker Corporation
    • 8.7.3.1. Company overview
    • 8.7.3.2. Financial performance
    • 8.7.3.3. Product benchmarking
    • 8.7.3.4. Strategic initiatives
  • 8.7.4. Zimmer Biomet
    • 8.7.4.1. Company overview
    • 8.7.4.2. Financial performance
    • 8.7.4.3. Product benchmarking
    • 8.7.4.4. Strategic initiatives
  • 8.7.5. Smith+Nephew
    • 8.7.5.1. Company overview
    • 8.7.5.2. Financial performance
    • 8.7.5.3. Product benchmarking
    • 8.7.5.4. Strategic initiatives
  • 8.7.6. NuVasive, Inc. (mergerd with Globus Medical)
    • 8.7.6.1. Company overview
    • 8.7.6.2. Financial performance
    • 8.7.6.3. Product benchmarking
    • 8.7.6.4. Strategic initiatives
  • 8.7.7. Arthrex, Inc.
    • 8.7.7.1. Company overview
    • 8.7.7.2. Financial performance
    • 8.7.7.3. Product benchmarking
    • 8.7.7.4. Strategic initiatives
  • 8.7.8. Acumed, LLC
    • 8.7.8.1. Company overview
    • 8.7.8.2. Financial performance
    • 8.7.8.3. Product benchmarking
    • 8.7.8.4. Strategic initiatives
  • 8.7.9. Paragon Medical (AMETEK)
    • 8.7.9.1. Company overview
    • 8.7.9.2. Financial performance
    • 8.7.9.3. Product benchmarking
    • 8.7.9.4. Strategic initiatives
  • 8.7.10. Globus Medical
    • 8.7.10.1. Company overview
    • 8.7.10.2. Financial performance
    • 8.7.10.3. Product benchmarking
    • 8.7.10.4. Strategic initiatives